Kobayashi Pharmaceutical Co (KBYPF) Income Statement
Kobayashi Pharmaceutical Co Income Statement
Last quarter (Q2 2026), Kobayashi Pharmaceutical Co's total revenue was $37.08B, an increase of 1.85% from the same quarter last year. In Q2, Kobayashi Pharmaceutical Co's net income was $101.00M. See Kobayashi Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 165.74B | $ 165.60B | $ 173.46B | $ 166.26B | $ 155.25B | |
| $ 84.71B | $ 87.60B | $ 96.38B | $ 92.33B | $ 88.77B | |
| $ 69.79B | $ 62.74B | $ 70.60B | $ 65.66B | $ 62.71B | |
| Depreciation and Amortization | $ 8.74B | $ 8.02B | $ 6.06B | $ 5.36B | $ 4.83B |
| $ 12.52B | $ 21.96B | $ 33.65B | $ 33.33B | $ 32.49B | |
| $ 14.92B | $ 24.86B | $ 25.78B | $ 26.67B | $ 26.07B | |
| $ -11.18B | $ -10.95B | $ 1.78B | $ 1.28B | $ 1.57B | |
| $ 3.74B | $ 13.91B | $ 27.56B | $ 27.95B | $ 27.64B | |
| $ 3.66B | $ 10.07B | $ 20.34B | $ 20.02B | $ 19.71B | |
| Per Share Metrics | |||||
| Basic EPS | $ 49.18 | $ 135.42 | $ 268.16 | $ 259.61 | $ 252.35 |
| Diluted EPS | $ 49.18 | $ 135.42 | $ 268.16 | $ 259.59 | $ 252.35 |
| Weighted Average Shares Outstanding | 74.34M | 74.34M | 75.84M | 77.12M | 78.13M |
| Weighted Average Shares Outstanding (Diluted) | 74.34M | 74.34M | 75.84M | 77.13M | 78.13M |
Currency in JPY
